EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

A Review of Vancomycin, Gentamicin, and Amikacin Population Pharmacokinetic Models in Neonates and Infants

Marta Albanell-Fernández iD, Montse Rodríguez-Reyes iD, Carla Bastida iD, Dolors Soy iD

Clinical Pharmacokinetics · 2025-01 · 64 (1) · 1-25

DOI: 10.1007/s40262-024-01459-z ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 16.01.2025. Verfasst von Marta Albanell-Fernández und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicines, Department of Pharmacy, Pharmacy Service, Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Amikacin, Vancomycin, Gentamicins, Anti-Bacterial Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Universitat de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Population pharmacokinetic (popPK) models are an essential tool when implementing therapeutic drug monitoring (TDM) and to overcome dosing challenges in neonates in clinical practice. Since vancomycin, gentamicin, and amikacin are among the most prescribed antibiotics for the neonatal population, we aimed to characterize the popPK models of these antibiotics and the covariates that may influence the pharmacokinetic parameters in neonates and infants with no previous pathologies. We searched the PubMed, Embase, Web of Science, and Scopus databases and the bibliographies of relevant articles from inception to the beginning of February 2024. The search identified 2064 articles, of which 68 met the inclusion criteria (34 for vancomycin, 21 for gentamicin, 13 for amikacin). A one-compartment popPK model was more frequently used to describe the pharmacokinetics of the three antibiotics (91.2% vancomycin, 76.9% gentamicin, 57.1% amikacin). Pharmacokinetic parameter (mean ± standard deviation) values calculated for a "typical" neonate weighing 3 kg were as follows: clearance (CL) 0.34 ± 0.80 L/h for vancomycin, 0.27 ± 0.49 L/h for gentamicin, and 0.19 ± 0.07 L/h for amikacin; volume of distribution (Vd): 1.75 ± 0.65 L for vancomycin, 1.54 ± 0.53 L for gentamicin, and 1.67 ± 0.27 L for amikacin for one-compartment models. Total body weight, postmenstrual age, and serum creatinine were common predictors (covariates) for describing the variability in CL, whereas only total body weight predominated for Vd. A single universal popPK model for each of the antibiotics reviewed cannot be implemented in the neonatal population because of the significant variability between them. Body weight, renal function, and postmenstrual age are important predictors of CL in the three antibiotics, and total body weight for Vd. TDM represents an essential tool in this population, not only to avoid toxicity but to attain the desired pharmacokinetic/pharmacodynamic index. The characteristics of the neonatal population, coupled with the lack of prospective studies and external validation of most models, indicate a need to continue investigating the pharmacokinetics of these antibiotics in neonates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmikacinVancomycinGentamicinsAnti-Bacterial AgentsModels, BiologicalHumansInfant, NewbornInfantDrug Monitoring

Substanzen

AmikacinVancomycinGentamicinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Medicines, Department of Pharmacy, Pharmacy Service, Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Division of Medicines, Department of Pharmacy, Pharmacy Service, Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona, Spain. cbastida@clinic.cat.
  • August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Department of Pharmacology, Toxicology and Therapeutic Chemistry, School of Pharmacy and Food Science, Universitat de Barcelona, Barcelona, Spain.

ORCID-Profile: Marta Albanell-Fernández, Montse Rodríguez-Reyes, Carla Bastida, Dolors Soy

Förderung

  • Universitat de Barcelona

Zitieren

APA

Albanell-Fernández, M., Rodríguez-Reyes, M., Bastida, C., & Soy, D. (2025). A Review of Vancomycin, Gentamicin, and Amikacin Population Pharmacokinetic Models in Neonates and Infants. Clinical Pharmacokinetics, 64(1), 1-25. https://doi.org/10.1007/s40262-024-01459-z

Vancouver

Albanell-Fernández M, Rodríguez-Reyes M, Bastida C, Soy D. A Review of Vancomycin, Gentamicin, and Amikacin Population Pharmacokinetic Models in Neonates and Infants. Clinical Pharmacokinetics. 2025;64(1):1-25. doi:10.1007/s40262-024-01459-z

BibTeX
@article{AlbanellFernndez2025,
  author = {Albanell-Fernández, Marta and Rodríguez-Reyes, Montse and Bastida, Carla and Soy, Dolors},
  title = {A Review of Vancomycin, Gentamicin, and Amikacin Population Pharmacokinetic Models in Neonates and Infants},
  journal = {Clinical Pharmacokinetics},
  year = {2025},
  volume = {64},
  number = {1},
  pages = {1--25},
  doi = {10.1007/s40262-024-01459-z}
}
Kostenlos starten →